Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_provenance.
• NP928368.RAQ0pfIA3dDJ6GMYQfF9mytJYDm911AdCnI1t6CVtoP4o130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928368.RAQ0pfIA3dDJ6GMYQfF9mytJYDm911AdCnI1t6CVtoP4o130_provenance.
• NP181745.RA09p8h2EzXp5jZFTgvVFXpWyhQAeQE5L-OeV-SE2ozhc130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181745.RA09p8h2EzXp5jZFTgvVFXpWyhQAeQE5L-OeV-SE2ozhc130_provenance.
• assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP656591.RAck7co78sZPq9cKCo5zhRTzsbE7qW0fCFfLPJhp_m1xk130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656591.RAck7co78sZPq9cKCo5zhRTzsbE7qW0fCFfLPJhp_m1xk130_provenance.
• NP656610.RAQJIVSM_AWbhUsKbS_wTUW5PWqofzhsV1AO5YL9HUui8130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656610.RAQJIVSM_AWbhUsKbS_wTUW5PWqofzhsV1AO5YL9HUui8130_provenance.
• assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP497596.RApEOnAxT4Rt6YcIrObs8DjAQgdZRe_A-frR2i1gE2C0A130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497596.RApEOnAxT4Rt6YcIrObs8DjAQgdZRe_A-frR2i1gE2C0A130_provenance.
• NP497597.RAsReCZ5YEBf14e7Ji0SmIHQQYsj7vJlelVFp5cYfOQUk130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497597.RAsReCZ5YEBf14e7Ji0SmIHQQYsj7vJlelVFp5cYfOQUk130_provenance.